 |
|
Health Technology News
Recent Business Newswire Stories from PRnetwire™ and eNewsChannels™
Edited by Christopher Simmons, senior news editor
Dr. Tin-Chuen Yeung Named To Health Discovery Corporation Scientific Advisory Board
WACO, Texas - Nov. 25, 2003 /Send2Press Newswire/ -- Health Discovery
Corporation (OTC Bulletin Board: HDVY), a biotechnology company which is
focused on biomarker and pathway discovery for diagnostic markers and
drug targets today announced the appointment of Dr. Tin-Chuen Yeung to
its Scientific Advisory Board.
Dr. Yeung is a pharmacologist and experienced researcher in
biotechnology. Besides his experience in research, he has substantial
experience in intellectual property law, business development,
technology evaluation and commercialization. He serves as an advisor to
venture capital and start-up biotechnology companies throughout the
United States.
Dr. Yeung is currently the Head of Strategic Development, Life Sciences,
for the Chicago law firm Bell Boyd & Lloyd, LLC. He is admitted to
practice patent law before the United States Patent Bar. At Bell Boyd &
Lloyd, he is also with the Intellectual Property group responsible for
patent prosecution in the areas of biotechnology, nanotechnology,
agricultural biotechnology, pharmaceuticals, drug delivery technologies,
medical devices and other life sciences. He also provides counseling to
clients in patent filing strategies and management of intellectual
property.
Prior to that, Dr. Yeung served as President of Everest International,
Inc. consultants to Fortune 500 medical technology companies and
start-up biotechnology companies. He also served as Director of
Strategy & Business Development for the Biosciences Division at Baxter
International, Inc., where he managed the strategic development for
worldwide development, marketing and manufacturing of recombinant
protein products. He also served as Director of Corporate Development
for Baxter, responsible for management of Baxter's acquisitions,
technology development, licensing, and strategic alliances.
Dr. Yeung worked for the G. D. Searle and NutraSweet Divisions of the
Monsanto Company (MON:NYSE) for several years as a research scientist,
and as manager of business ventures managing the evaluation and
commercialization of new technologies. Prior to joining Monsanto, he
was a research fellow at Harvard Medical School, Department of
Pharmacology, studying the mechanisms of action and toxicity of
anti-cancer drugs.
Dr. Yeung received Bachelor of Science in Biochemistry and Doctor of
Philosophy in Pharmacology degrees from the State University of New York
and a Master of Management from Northwestern University's Kellogg
Graduate School of Management with concentrations in Finance, Marketing,
and Management of Information Systems.
"It is rare to find in one individual the unique combination of a
doctoral degree in pharmacology, an MBA, a biotechnology business
development background, as well as, the expertise and knowledge to
practice patent law before the United States Patent Bar. We are
extremely honored that Dr. Yeung with his vast and unique experience has
agreed to become a member of our Scientific Advisory Board," said
Stephen D. Barnhill, M.D., Chairman and CEO of Health Discovery
Corporation. "Dr. Yeung will bring significant commercialization and
patent experience and expertise to our team of Scientific Advisors as we
move to create a commercial market for our patent protected biomarker
discoveries used for diagnostic and pharmaceutical applications."
Dr. Yeung commented, "I believe that computational medicine and machine
learning can significantly reduce both the time and the cost of
developing new diagnostic tests and new therapies. I am looking forward
to working with Dr. Barnhill and his team of experts at Health Discovery
Corporation to achieve this goal."
This news release contains
"forward-looking statements" within the meaning of Section 27a of the
Securities Acts of 1933 and Section 21E of the Securities Exchange Act
of 1934. Although the Company believes that the expectations reflected
in such forward-looking statements are reasonable, it can give no
assurance that such expectations will prove correct.
Organization Website:
www.dwcell.com
Source of News:
Health Discovery Corporation
Find More Stock Info, Charts, News on OTC BB: HDVY
• Yahoo!® Finance (HDVY.OB)
• Quote.com (BB:HDVY)
• MSN Money (HDVY)
Texas Business Newswire
/
Health Technology Newswire
• Previous News from Health Discovery Corporation
Nov. 14, 2003
DHealth Discovery Corporation, Inc. Announces the Appointment of Joe Fanelli to the Management Team as Director of Corporate Development
Nov. 6, 2003
Dprof. Dr. Bernhard Scholkopf, Max Plank Director, Named To Health Discovery Corporation Scientific Advisory Board
Nov. 6, 2003
Direct Wireless Communications Inc. Announces Name Change To Health Discovery Corporation
Nov. 3, 2003
Direct Wireless Communications, Inc. Announces The Appointment Of David Cooper, M.D., Ph.D. To The Board Of Directors And The Management Team
Oct. 31, 2003
Direct Wireless Communications, Inc. Announces Agreement With Md Anderson Cancer Center For Cancer Discovery
Oct. 27, 2003
Direct Wireless Communications, Inc. Announces Board And Management Changes
Oct. 2, 2003
Ramananda K. Madyastha, M.D., Ph.D., Award Winning Cancer Researcher Named To Direct Wireless Communications Scientific Advisory Board
Oct. 2, 2003
Ramananda K. Madyastha, M.D., Ph.D., Award Winning Cancer Researcher Named To Direct Wireless Communications Scientific Advisory Board
Sept. 25, 2003
Direct Wireless Completes Acquisition Of The Barnhill Group
Sept. 18, 2003
Direct Wireless Communications Hosts Reception For 15th Annual Genomic Sequencing And Analysis Conference Held By The Institute For Genomic Research (Tigr) In Savannah, Georgia
Sept. 9, 2003
Dr. Kary Mullis, Nobel Prize Winning Chemist Named To Direct Wireless Communications Scientific Advisory Board
Sept. 3, 2003
Dr. Herbert Fritsche Presents Cancer Discovery At International Cancer Meeting
Sept. 2, 2003
Direct Wireless Enters Into A Letter Of Agreement To Acquire Fractal Genomics
August 26, 2003
Direct Wireless Enters Into A Letter Of Agreement To Acquire The Barnhill Group
Find more news like this:
> More Health Technology News
>
More Texas Business News
> Other Recent Business News Stories
> Other Business Newswire Channels
FOR INFORMATION ABOUT THE COMPANY OR ORGANIZATION(S) MENTIONED IN THE ABOVE BUSINESS NEWS ITEM, PLEASE CONTACT THE COMPANY DIRECTLY. SEND2PRESS/NEOTROPE IS NOT A REPRESENTATIVE OF, AND DOES NOT OFFER FURTHER INFORMATION ABOUT, ANY COMPANY MENTIONED IN THE ABOVE NEWS ITEM(S).
DISCLAIMER: the above business news article is believed accurate but not guaranteed, and is based on business news supplied by the company or organization mentioned and/or quoted in the story. Neotrope/Send2Press makes no claims of accuracy or suitability for any purpose. Any opinions expressed by representatives of company(s) mentioned in news item are solely those of the person indicated, and do not reflect any opinion or policy of Neotrope/Send2Press. Your use of any information contained herein is done solely at your own risk, and you are fully responsible for using any information herein, or on sites mentioned or linked to in the article. Reproduction of this news article in any form requires written authorization. You may freely link to this article. PRnetwire™ (www.PRnetwire.com) is a unit of Neotrope, and is not related to PR Newswire®. Keyword marketing technology by DotComMojo™, a unit of Neotrope.
NEWSWIRE TERMS OF USE
|
|
|
|
Add Our News Headlines to Your Website Free
Free headline feed
Journalists & Editors
Choose your news by
preferred topic(s).
Privacy protected.
MORE INFO
Archived Releases
Most Recent Releases
NOTICE: THIS PAGE IS ARCHIVAL CONTENT AND SHOULD NOT BE RELIED UPON FOR ACCURACY.
|
|
|
